Skip to main content

01-07-2018 | Juvenile idiopathic arthritis | Article

Growth during tocilizumab therapy for polyarticular-course juvenile idiopathic arthritis: 2-year data from a phase III clinical trial

Bharucha KN et al. J Rheumatol 2018. doi: 10.3899/jrheum.170326

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics

EULAR 2020 E-Congress hub

Access the latest news and expert video commentary from the EULAR 2020 E-Congress.

Image Credits